Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "us" return 99 results.
Seeking Projects Advancing Human-Animal Bond >
Event seeks innovative solutions for the well-being and care of companion animals and their pet parents.
PANOQUELL®-CA1 (fuzapladib sodium for injection) is now available in the U.S. >
The first and only drug conditionally approved by the FDA for management of the symptoms associated with acute onset of canine pancreatitis
Ceva Launches Wildlife Research Fund >
Ceva Wildlife Research Fund, the first endowment fund dedicated to research to protect wildlife.
Terms and Conditions >
TERMS AND CONDITIONS OF SALE
CEVA EXPANDS ORAL RABIES VACCINE PORTFOLIO WITH THE ACQUISITION OF CANADIAN FIRM ARTEMIS TECHNOLOGIES, INC. >
Libourne, May 16, 2022 – Ceva Santé Animale (Ceva) has acquired the Canadian oral rabies vaccine manufacturer Artemis Technologies, Inc. Artemis, located in Guelph, ON, Canada, produces ONRAB®, a ra...
Program Receives Quality Recognition >
Ceva’s U.S. C.H.I.C.K Program receives independently audited quality recognition from Bureau Veritas
Ceva Returns Strong Double-Digit Growth in 2019; Plans to Double sales by 2020. >
Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019.
Ceva Helps to Expand COVID-19 Testing >
MAWD Pathology increases same-day COVID-19 testing using equipment on loan from Ceva
Ceva Sponsors Kitten Bowl VI to Shine Spotlight on Pet Adoption >
Ceva Animal Health is kicking off kitten adoption season as a marquis sponsor of Hallmark Channel’s upcoming Kitten Bowl VI, the newest installment of the nation’s most beloved feline faceoff, featur...
CEVA LAUNCHES FIRST FDA-APPROVED GENERIC OF MILBEMYCIN OXIME IN U.S. >
Ceva Animal Health has launched MilbeGuard™ (milbemycin oxime) Flavored Tablets, the first FDA-approved generic milbemycin oxime in the U.S. MilbeGuard is a monthly, beef-flavored tablet that preve...